Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Metastasis is driven by sequential elevation of H-ras and Smad2 levels

Nature Cell Biology volume 4, pages 487–494 (2002)Cite this article

Abstract

Metastasis is a multistep process that involves local tumour invasion followed by dissemination to, and re-establishment at, distant sites. Here we show that during multistage tumorigenesis, discrete expression thresholds of activated Smad2 and H-ras are sequentially surpassed, driving tumour progression through distinct phases from a differentiated squamous carcinoma to a motile invasive stage, followed by an overt change from epithelial to mesenchymal cell type, finally culminating in metastatic tumour spread. Smad2 activation alone induces migration of tumour cells. Elevated H-ras levels, however, are required for nuclear accumulation of Smad2, both of which are essential for the epithelial–mesenchymal transition (EMT). Having undergone EMT, fibroblastoid carcinoma cells with elevated levels of activated Smad2, gain the capability to spread to a wide variety of tissues by a further increase in Smad2 expression. These findings have far-reaching implications for the prevention of tumour growth, invasion and metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Smad2 activation is elevated in invasive tumour cells.
Figure 2: Co-expression of H-ras and Smad2 is sufficient to induce EMT of squamous carcinoma cells.
Figure 3: Smad2 and/or Smad3 cooperate with H-ras to induce EMT of squamous carcinoma cells.
Figure 4: Smad2 inhibits proliferation but is necessary for the EMT and for tumour cells to become invasive.
Figure 5: Expression of Smad2dom.act augments metastasizing capability of spindle tumour cells.
Figure 6: Spindle, but not squamous, carcinoma cells show nuclear localization of phosphorylated Smad2 in vivo.

Similar content being viewed by others

References

  1. Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signalling in tumor suppression and cancer progression. Nature Genet. 29, 117–129 (2001).

    Article  CAS  PubMed  Google Scholar 

  2. Akhurst, R. J. & Derynck, R. TGF-β signalling in cancer — a double-edged sword. Trends Cell Biol 11, S44–S51 (2001).

    CAS  PubMed  Google Scholar 

  3. Cui, W. et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531–542 (1996).

    Article  CAS  PubMed  Google Scholar 

  4. Caulin, C., Scholl, F. G., Frontelo, P., Gamallo, C. & Quintanilla, M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ. 6, 1027–1035 (1995).

    CAS  PubMed  Google Scholar 

  5. Miettinen, P. J., Ebner, R., Lopez, A. R. & Derynck, R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127, 2021–2036 (1994).

    Article  CAS  PubMed  Google Scholar 

  6. Oft, M. et al. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462–2477 (1996).

    Article  CAS  PubMed  Google Scholar 

  7. Oft, M., Heider, K. H. & Beug, H. TGFβ signalling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8, 1243–1252 (1998).

    Article  CAS  PubMed  Google Scholar 

  8. Portella, G. et al. TGFβ is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for invasion and metastasis. Cell Growth Differ. 9, 393–404 (1998).

    CAS  PubMed  Google Scholar 

  9. Bhowmick, N. A. et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12, 27–36 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. & Arteaga, C. L. Phosphatidylinositol-3 kinase function is required for TGFβ-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803–36810 (2000).

    Article  CAS  PubMed  Google Scholar 

  11. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C. H. & ten Dijke, P. TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 112, 4557–4568 (1999).

    CAS  PubMed  Google Scholar 

  12. Lehmann, K. et al. Raf induces TGFb production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14, 2610–2622 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S. & Sonenshein, G. E. Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol. Cell. Biol. 20, 5381–5391 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Janda, E. et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299–313 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kretzschmar, M., Doody, J., Timokhina, I. & Massague, J. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13, 804–816 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Whitman, M. & Melton, D. A. Involvement of p21ras in Xenopus mesoderm induction. Nature 357, 252–254 (1992).

    Article  CAS  PubMed  Google Scholar 

  17. Umbhauer, M., Marshall, C. J., Mason, C. S., Old, R. W. & Smith, J. C. Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature 376, 58–62 (1995).

    Article  CAS  PubMed  Google Scholar 

  18. Green, J. B., New, H. V. & Smith, J. C. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71, 731–739 (1992).

    Article  CAS  PubMed  Google Scholar 

  19. Baker, J. C. & Harland, R. M. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880–1889 (1996).

    Article  CAS  PubMed  Google Scholar 

  20. Nomura, M. & Li, E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393, 786–790 (1998).

    Article  CAS  PubMed  Google Scholar 

  21. Buchmann, A., Ruggeri, B., Klein-Szanto, A. J. & Balmain, A. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res. 51, 4097–4101 (1991).

    CAS  PubMed  Google Scholar 

  22. Burns, P. A. et al. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene 6, 2363–2369 (1991).

    CAS  PubMed  Google Scholar 

  23. Abe, M. et al. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276–284 (1994).

    Article  CAS  PubMed  Google Scholar 

  24. Macias-Silva, M. et al. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215–1224 (1996).

    Article  CAS  PubMed  Google Scholar 

  25. Massague, J. & Wotton, D. Transcriptional control by the TGF-β/Smad signalling system. EMBO J. 19, 1745–1754 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Miyazono, K., ten Dijke, P. & Heldin, C. H. TGF-β signaling by Smad proteins. Adv. Immunol. 75, 115–157 (2000).

    Article  CAS  PubMed  Google Scholar 

  27. Seftor, R. E. Role of the b3 integrin subunit in human primary melanoma progression: multifunctional activities associated with α(v)3 integrin expression. Am. J. Pathol. 153, 1347–1351 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Xie, W. et al. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res. 62, 497–505 (2002).

    CAS  PubMed  Google Scholar 

  29. Frame, S. & Balmain, A. Integration of positive and negative growth signals during ras pathway activation in vivo. Curr. Opin. Genet. Dev. 10, 106–113 (2000).

    Article  CAS  PubMed  Google Scholar 

  30. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682–4689 (1989).

    CAS  PubMed  Google Scholar 

  31. Derynck, R. et al. Human transforming growth factor-b complementary DNA sequence and expression in normal and transformed cells. Nature 316, 701–705 (1985).

    Article  CAS  PubMed  Google Scholar 

  32. Friedman, E. et al. High levels of transforming growth factor b 1 correlate with disease progression in human colon cancer. Cancer Epidemiol. Biomarkers Prev. 4, 549–554 (1995).

    CAS  PubMed  Google Scholar 

  33. Shim, K. S., Kim, K. H., Han, W. S. & Park, E. B. Elevated serum levels of transforming growth factor-b1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer 85, 554–561 (1999).

    Article  CAS  PubMed  Google Scholar 

  34. Green, J. B. & Smith, J. C. Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate Nature 347, 391–394 (1990).

    Article  CAS  PubMed  Google Scholar 

  35. Massague, J. & Chen, Y. G. Controlling TGF-β signaling. Genes Dev. 14, 627–644 (2000).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grant K01 CA84244 from the NCI.

Author information

Author notes

  1. Martin Oft

    Present address: Department of Oncology, DNAX Research Institute, 901 California Avenue, Palo Alto, California, 94304, USA

Authors and Affiliations

  1. University of California at San Francisco Comprehensive Cancer Center, Box 0875, San Francisco, 94143-0875, California, USA

    Martin Oft, Rosemary J. Akhurst & Allan Balmain

  2. Onyx Pharmaceuticals, 3031 Research Drive, Building A, Richmond, California, USA

    Martin Oft, Rosemary J. Akhurst & Allan Balmain

Authors
  1. Martin Oft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosemary J. Akhurst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allan Balmain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allan Balmain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oft, M., Akhurst, R. & Balmain, A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4, 487–494 (2002). https://doi.org/10.1038/ncb807

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb807

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing